Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tilray Inc    TLRY

TILRAY INC

(TLRY)
My previous session
Most popular
 SummaryQuotesChartsNewsRatingsCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/18/2019 03/19/2019 03/20/2019 03/21/2019 03/22/2019 Date
72.34(c) 69.79(c) 70.73(c) 70.25(c) 67.16(c) Last
3 530 506 4 219 291 1 821 088 1 097 303 1 603 816 Volume
-0.22% -3.53% +1.35% -0.68% -4.40% Change
More quotes
Company
Tilray Inc is a Canada-based company engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. It also supplies... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Tilray Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on TILRAY INC
03/19TILRAY : Thinking about buying stock in Altimmune Inc., Dare Bioscience Inc., Ph..
PR
03/18TILRAY : B.C. cannabis producer Tilray reports Q4 revenue surge, deeper net loss
AQ
03/18TILRAY, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
03/18TILRAY, INC. : Reports Full Year 2018 Financial Results
BU
03/18GLOBAL MARKETS LIVE : ING, Boeing, GM, Worldpay…
03/17TILRAY : Five things to watch for in the Canadian business world in the coming w..
AQ
03/15LIVEWELL CANADA : Finalizes Hemp CBD Supply Agreement with Tilray
AQ
03/13TILRAY : reg; Expands Global Leadership Team with Appointment of Chief Corporate..
BU
03/07TILRAY : Announces Successful Medical Cannabis Harvest in Portugal and Provides ..
AQ
03/06TILRAY : reg; Announces Successful Medical Cannabis Harvest in Portugal and Prov..
BU
More news
Analyst Recommendations on TILRAY INC
More recommendations
Sector news : Pharmaceuticals - NEC
03/22FDA Rejects Oral Treatment for Type 1 Diabetes - Update
DJ
03/22ALLERGAN : promises independent board chair in next leadership change
RE
03/22FDA Rejects Oral Treatment for Type 1 Diabetes
DJ
03/22UPS to Test In-Home Vaccine Service in U.S. -Reuters
DJ
03/22JOHNSON & JOHNSON : J&J Unit Seeks Europe OK of Darzalex Combination in Multiple..
DJ
More sector news : Pharmaceuticals - NEC
Chart TILRAY INC
Duration : Period :
Tilray Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY INC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Managers
NameTitle
Brendan Kennedy President, Chief Executive Officer & Director
Greg Christopher Executive Vice President-Operations
Mark Castaneda Chief Financial Officer, Secretary & Treasurer
Joshua Eades Chief Science Officer & Vice President
Christine Thompson St. Clare Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TILRAY INC-4.79%6 545
JOHNSON & JOHNSON6.09%367 729
NOVARTIS10.85%239 412
PFIZER-4.12%235 119
ROCHE HOLDING LTD.11.20%234 784
MERCK AND COMPANY8.56%214 112